These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1021 related items for PubMed ID: 17582498

  • 21. Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy.
    Hirami Y, Tsujikawa A, Otani A, Yodoi Y, Aikawa H, Mandai M, Yoshimura N.
    Retina; 2007 Mar; 27(3):335-41. PubMed ID: 17460589
    [Abstract] [Full Text] [Related]

  • 22. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
    Augustin AJ, Schmidt-Erfurth U.
    Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
    [Abstract] [Full Text] [Related]

  • 23. Two-year results of photodynamic therapy for polypoidal choroidal vasculopathy.
    Kurashige Y, Otani A, Sasahara M, Yodoi Y, Tamura H, Tsujikawa A, Yoshimura N.
    Am J Ophthalmol; 2008 Oct; 146(4):513-519. PubMed ID: 18614133
    [Abstract] [Full Text] [Related]

  • 24. Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin.
    Schmidt-Erfurth UM, Michels S.
    Ophthalmology; 2003 Jul; 110(7):1306-14. PubMed ID: 12867383
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Photodynamic therapy with verteporfin in polypoidal choroidal vasculopathy: results after 3 years of follow-up.
    Leal S, Silva R, Figueira J, Cachulo ML, Pires I, de Abreu JR, Cunha-Vaz JG.
    Retina; 2010 Sep; 30(8):1197-205. PubMed ID: 20827139
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Polypoidal choroidal vasculopathy masquerading as neovascular age-related macular degeneration refractory to ranibizumab.
    Stangos AN, Gandhi JS, Nair-Sahni J, Heimann H, Pournaras CJ, Harding SP.
    Am J Ophthalmol; 2010 Nov; 150(5):666-73. PubMed ID: 20719300
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Polypoidal choroidal vasculopathy].
    Yuzawa M.
    Nippon Ganka Gakkai Zasshi; 2012 Mar; 116(3):200-31; discussion 232. PubMed ID: 22568102
    [Abstract] [Full Text] [Related]

  • 31. Photodynamic therapy for age-related macular degeneration in Japanese patients: results after one year.
    Ogino T, Takeda M, Imaizumi H, Okushiba U.
    Jpn J Ophthalmol; 2007 Mar; 51(3):210-5. PubMed ID: 17554484
    [Abstract] [Full Text] [Related]

  • 32. Extensive submacular haemorrhage in polypoidal choroidal vasculopathy managed by sequential gas displacement and photodynamic therapy: a pilot study of one-year follow up.
    Chan WM, Liu DT, Lai TY, Li H, Tong JP, Lam DS.
    Clin Exp Ophthalmol; 2005 Dec; 33(6):611-8. PubMed ID: 16402954
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Intravitreal bevacizumab for exudative branching vascular networks in polypoidal choroidal vasculopathy.
    Wakabayashi T, Gomi F, Sawa M, Tsujikawa M, Nishida K.
    Br J Ophthalmol; 2012 Mar; 96(3):394-9. PubMed ID: 21719568
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 52.